InvestSMART

Elixinol Wellness Limited (ASX: EXL) - Announcements

- Current share price for EXL : $0.008

ASX company news and announcements for Elixinol Wellness Limited (EXL) are delayed by 20 minutes from the time of their release between 7.30am and 7.30pm EDT and are in PDF format. All Elixinol Wellness Limited (EXL) ASX announcements deemed to be price sensitive will be highlighted with . If you are looking for ASX announcements for companies other than Elixinol Wellness Limited (EXL), please use our Company Announcements tool to search across all ASX-listed companies.

Latest company announcements for Elixinol Wellness Limited (EXL)

Search all Announcements
Market Cap ($m) Headline Release
date/time+		 Price at
release+		 Current
price+		 Gain/Loss View
$3 Elixinol Global completes 50.5% investment in Elixinol Japan 6 Nov 2018 8:31AM $1.920 $0.008 fallen by 99.61%
$3 Raw with Life Change of Substantial Holder 5 Nov 2018 8:01PM $1.920 $0.008 fallen by 99.61%
$3 D&G Health Change of Substantial Holder 5 Nov 2018 7:58PM $1.920 $0.008 fallen by 99.61%
$3 EXL Change of Substantial Holder 5 Nov 2018 7:51PM $1.920 $0.008 fallen by 99.61%
$3 Appendix 3B 1 Nov 2018 5:49PM $1.945 $0.008 fallen by 99.61%
$3 EXL Sydney Wholesale Investor Presentation 31 Oct 2018 10:31AM $1.800 $0.008 fallen by 99.58%
$3 Quarterly Report and Appendix 4C 30 Oct 2018 8:48AM $1.585 $0.008 fallen by 99.53%
$3 EXL Aust Microcap Investment Conference Presentation 17 Oct 2018 4:54PM $1.925 $0.008 fallen by 99.61%
$3 Cleansing Statement and Appendix 3B 4 Oct 2018 10:25AM $1.965 $0.008 fallen by 99.62%
$3 Elixinol Global raises A$40m to accelerate international gro 28 Sep 2018 10:14AM $2.150 $0.008 fallen by 99.65%
$3 Trading Halt 26 Sep 2018 6:01PM $2.150 $0.008 fallen by 99.65%
$3 EXL increases ownership in Elixinol Japan 24 Sep 2018 8:40AM $2.000 $0.008 fallen by 99.63%
$3 EXL Commences Trading on OTCQX Market in United States 18 Sep 2018 8:46AM $2.040 $0.008 fallen by 99.63%
$3 EXL Presentation for Investor Briefings September 2018 6 Sep 2018 2:41PM $1.705 $0.008 fallen by 99.56%
$3 1H FY2018 Results Conference Call Recording 30 Aug 2018 11:48AM $1.510 $0.008 fallen by 99.50%
$3 1H 2018 Investor Results Presentation 29 Aug 2018 8:08AM $1.430 $0.008 fallen by 99.48%
$3 1H 2018 Results ASX Announcement 29 Aug 2018 8:08AM $1.430 $0.008 fallen by 99.48%
$3 Appendix 4D and 1H 2018 Interim Report 29 Aug 2018 8:07AM $1.430 $0.008 fallen by 99.48%
$3 Elixinol Global 1H FY2018 results conference call 24 Aug 2018 1:09PM $1.370 $0.008 fallen by 99.45%
$3 Quarterly Report and Appendix 4C 30 Jul 2018 10:02AM $1.455 $0.008 fallen by 99.48%
$3 Historic US Hemp Farming Legislation Passed 29 Jun 2018 10:32AM $1.380 $0.008 fallen by 99.46%
$3 Change of Director's Interest Notice - S Karousos 17 May 2018 3:39PM $1.700 $0.008 fallen by 99.56%
$3 Change of Director's Interest Notice - P Benhaim 17 May 2018 3:38PM $1.700 $0.008 fallen by 99.56%
$3 Change of Directors Interest Notice - L McLeod 17 May 2018 3:35PM $1.700 $0.008 fallen by 99.56%
$3 Change of Directors Interest Notice A Duff 17 May 2018 3:32PM $1.700 $0.008 fallen by 99.56%

576 - 600 of 673 results

Page 24 of 27

  • + Company announcements and prices are delayed by least 20 minutes. Prices are indicative only.

DISCLOSURE: InvestSMART Group Limited employees may have an interest in the securities and managed funds displayed via this service. Please refer to our Financial Services Guide for more information.

Data shown on this website is sourced by Morningstar
© Morningstar. All rights reserved. Neither any Morningstar company nor any of their content providers guarantee the data or content contained herein to be accurate, complete or timely nor will they have any liability for its use or distribution. Any general advice has been prepared by Morningstar Australasia Pty Ltd (ABN: 95 090 665 544, AFSL: 240892) and/or Morningstar Research Limited, subsidiaries of Morningstar, Inc, without reference to your objectives, financial situation or needs. You should consider the advice in light of these matters and, if applicable, the relevant Product Disclosure Statement (in respect of Australian products) or Investment Statement (in respect of New Zealand products) before making any decision to invest. No Morningstar-affiliated company or any of their employees is providing you with personalised financial advice. To obtain advice tailored to your particular circumstances, please contact a professional financial adviser. Some material is copyright and published under licence from ASX Operations Pty Limited ACN 004 523 782 ("ASXO"). Data and content is provided for personal use only.